Intronic single-nucleotide polymorphisms in Bcl-2 are associated with chronic obstructive pulmonary disease severity

Respirology

Volumn 12, Issue 1, 2007, Pages 34-41

  Sata, Makoto ^a,b   Takabatake, Noriaki ^a   Inoue, Sumito ^a   Shibata, Yoko ^a   Abe, Shuichi ^a   Machiya, Jun Ichi ^a   Wada, Toshihiro ^a   Ji, Guijin ^c   Kido, Takashi ^c   Matsuura, Tadashi ^c   Muramatsu, Masa Aki ^c   Kubota, Isao ^a  

^a YAMAGATA UNIVERSITY   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^c HuBit Genomix Research Institute   (Japan)

Author keywords

Bcl 2; COPD; Lung function; Polymorphism; Severity

Indexed keywords

PROTEIN BCL 2;

AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; DNA POLYMORPHISM; GENE LINKAGE DISEQUILIBRIUM; GENE MAPPING; GENE STRUCTURE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC TRAIT; HAPLOTYPE; HUMAN; INTRON; JAPAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; DNA; FORCED EXPIRATORY VOLUME; GENES, BCL-2; GENOTYPE; HUMANS; INTRONS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 33845700053     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2006.00959.x     Document Type: Article

References (39)

1. Burrows B, Knudson RJ, Cline MG, Lebowitz MD. Quantitative relationships between cigarette smoking and ventilatory function. Am. Rev. Respir. Dis 1977; 115: 195-205.
2. Fletcher C, Peto R. The natural history of chronic airflow obstruction. BMJ 1977; 1: 1645-8.
3. Silverman EK, Speizer FE. Risk factors for the development of chronic obstructive pulmonary disease. Med. Clin. North. Am. 1996; 80: 501-22.
4. Sandford AJ, Weir TD, Pare PD. Genetic risk factors for chronic obstructive pulmonary disease. Eur. Respir. J. 1997; 10: 1380-91.
5. Segura-Valdez L, Pardo A, Gaxiola M, Uhal BD, Becerril C, Selman M. Upregulation of gelatinases A and B, collagenases 1 and 2, and increased parenchymal cell death in COPD. Chest 2000; 117: 684-94.
6. Kasahara Y, Tuder RM, Cool CD, Lynch DA, Flores SC, Voelkel NF. Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema. Am. J. Respir. Crit. Care Med. 2001; 163: 737-44.
7. Majo J, Ghezzo H, Cosio MG. Lymphocyte population and apoptosis in the lungs of smokers and their relation to emphysema. Eur. Respir. J. 2001; 17: 946-53.
8. Yokohori N, Aoshiba K, Nagai A, Respiratory Failure Research Group in Japan. Increased levels of cell death and proliferation in alveolar wall cells in patients with pulmonary emphysema. Chest 2004; 125: 626-32.
9. Kasahara Y, Tuder RM, Taraseviciene-Stewart L et al. Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J. Clin. Invest. 2000; 106: 1311-19.
10. Aoshiba K, Yokohori N, Nagai A. Alveolar wall apoptosis causes lung destruction and emphysematous changes. Am. J. Respir. Cell Mol. Biol. 2003; 28: 555-62.
11. Kerr JF, Winterford CM, Harmon BV. Apoptosis. Its significance in cancer and cancer therapy. (Published erratum appears in Cancer 1994; 73 : 3108.) Cancer 1994; 73: 2013-26.
12. Raff MC. Social controls on cell survival and cell death. Nature 1992; 356: 397-400.
13. White E. Life, death, and the pursuit of apoptosis. Genes Dev. 1996; 10: 1-15.
14. Tsujimoto Y, Gorham J, Cossman J, Jaffe E, Croce CM. The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining. Science 1985; 229: 1390-3.
15. Hockenbery D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990; 348: 334-6.
16. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995; 267: 1456-62.
17. Tesfaigzi J, Hotchkiss JA, Harkema JR. Expression of the Bcl-2 protein in nasal epithelia of F344/N rats during mucous cell metaplasia and remodeling. Am. J. Respir. Cell Mol. Biol. 1998; 18: 794-9.
18. Harris JF, Fischer MJ, Hotchkiss JR et al. Bcl-2 sustains increased mucous and epithelial cell numbers in metaplastic airway epithelium. Am. J. Respir. Crit. Care Med. 2005; 171: 764-72.
19. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1995; 152: S77-120.
20. Japanese Society of Chest Disease. Standards of pulmonary function tests for Japanese. Jpn J. Thorac. Dis. 1993; 31: appendix.
21. Ranade K, Chang MS, Ting CT et al. High-throughput genotyping with single nucleotide polymorphisms. Genome Res. 2001; 11: 1262-8.
22. Kitamura Y, Moriguchi M, Kaneko H et al. Determination of probability distribution of diplotype configuration (diplotype distribution) for each subject from genotypic data using the EM algorithm. Ann. Hum. Genet. 2002; 66: 183-93.
23. Sham PC, Curtis D. Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann. Hum. Genet. 1995; 59: 97-105.
24. Wildt AR, Ahtola OT. Analysis of Covariance. Quantitative Applications in the Social Sciences Series No. 12. Sage Publications, Thousand Oaks, 1978.
25. Ozaki K, Ohnishi Y, Iida A et al. Functional SNPs in the lymphotoxin-α gene that are associated with susceptibility to myocardial infarction. (Published erratum appears in Nat. Genet. 2003; 33 : 107.) Nat. Genet. 2002; 32: 650-4.
26. Surinya KH, Cox TC, May BK. Identification and characterization of a conserved erythroid-specific enhancer located in intron 8 of the human 5-aminolevulinate synthase 2 gene. J. Biol. Chem. 1998; 273: 16798-809.
27. Ghayor C, Herrouin JF, Chadjichristos C et al. Regulation of human COL2A1 gene expression in chondrocytes. Identification of C-Krox-responsive elements and modulation by phenotype alteration. J. Biol. Chem. 2000; 275: 27421-38.
28. Beohar N, Kawamoto S. Transcriptional regulation of the human nonmuscle myosin II heavy chain-A gene. Identification of three clustered cis-elements in intron-1 which modulate transcription in a cell type- and differentiation state-dependent manner. J. Biol. Chem. 1998; 273: 9168-78.
29. Tokuhiro S, Yamada R, Chang X et al. An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis. Nat. Genet. 2003; 35: 341-8.
30. Chao DT, Korsmeyer SJ. BCL-2 family: regulators of cell death. Annu. Rev. Immunol. 1998; 16: 395-419.
31. O'Shaughnessy TC, Ansari TW, Barnes NC, Jeffery PK. Inflammation in bronchial biopsies of subjects with chronic bronchitis: inverse relationship of CD8+ T lymphocytes with FEV1. Am. J. Respir. Crit. Care Med. 1997; 155: 852-7.
32. Saetta M, Di Stefano A, Turato G et al. CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1998; 157: 822-6.
33. Lams BE, Sousa AR, Rees PJ, Lee TH. Immunopathology of the small-airway submucosa in smokers with and without chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1998; 158: 1518-23.
34. Lu QL, Poulsom R, Wong L, Hanby AM. Bcl-2 expression in adult and embryonic non-haematopoietic tissues. J. Pathol. 1993; 169: 431-7.
35. Kagi D, Ledermann B, Burki K, Zinkernagel RM, Hengartner H. Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Annu. Rev. Immunol. 1996; 14: 207-32.
36. Liu CC, Young LH, Young JD. Lymphocyte-mediated cytolysis and disease. N. Engl. J. Med. 1996; 335: 1651-9.
37. Tesfaigzi Y, Fischer MJ, Martin AJ, Seagrave J. Bcl-2 in LPS- and allergen-induced hyperplastic mucous cells in airway epithelia of Brown Norway rats. Am. J. Physiol. Lung Cell. Mol. Physiol. 2000; 279: L1210-17.
38. Lebowitz MD, Burrows B. The relationship of acute respiratory illness history to the prevalence and incidence of obstructive lung disorders. Am. J. Epidemiol. 1977; 105: 544-54.
39. Hogg JC, Chu F, Utokaparch S et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N. Engl. J. Med. 2004; 350: 2645-53.